Long-term Outcomes Following Esophagectomy in Older and Younger Adults with Esophageal Cancer
Background Patterns of overall and disease-free survival after esophagectomy for esophageal cancer in older adults have not been carefully studied. Methods Retrospective analysis of all patients with esophageal cancer undergoing esophagectomy from 2005 to 2020 at our institution was performed. Differences in outcomes were stratified by age groups, < 75 and ≥ 75 years old, and two time periods, 2005–2012 and 2013–2020. Results A total of 1135 patients were included: 979 (86.3%) patients were < 75 (86.3%), and 156 (13.7%) were ≥ 75 years old. Younger patients had fewer comorbidities, better nutritional status, and were more likely to receive neoadjuvant and adjuvant therapy (all p < 0.05). However, tumor stage and operative approach were similar, except for increased performance of the McKeown technique in younger patients (p = 0.02). Perioperatively, younger patients experienced fewer overall and grade II complications (both p < 0.05). They had better overall survival (log-rank p-value < 0.001) and median survival, 62.2 vs. 21.5 months (p < 0.05). When stratified by pathologic stage, survival was similar for yp0 and pathologic stage II disease (both log-rank p-value > 0.05). Multivariable Cox models showed older age (≥ 75 years old) had increased hazard for reduced overall survival (HR 2.04 95% CI 1.5–2.8; p < 0.001) but not disease-free survival (HR 1.1 95% CI 0.78–1.6; p = 0.54). Over time, baseline characteristics remained largely similar, while stage became more advanced with a rise in neoadjuvant use and increased performance of minimally invasive esophagectomy (all p < 0.05). While overall complication rates improved (p < 0.05), overall and recurrence-free survival did not. Overall survival was better in younger patients during both time periods (both log-rank p < 0.05). Conclusions Despite similar disease-free survival rates, long-term survival was decreased in older adults as compared to younger patients. This may be related to unmeasured factors including frailty, long-term complications after surgery, and competing causes of death. However, our results suggest that survival is similar in those with complete pathologic responses..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Journal of gastrointestinal surgery - 26(2022), 6 vom: 31. März, Seite 1119-1131 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dezube, Aaron R. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Society for Surgery of the Alimentary Tract 2022 |
|---|
| doi: |
10.1007/s11605-022-05295-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2078874108 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2078874108 | ||
| 003 | DE-627 | ||
| 005 | 20230516213652.0 | ||
| 007 | tu | ||
| 008 | 221220s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11605-022-05295-z |2 doi | |
| 035 | |a (DE-627)OLC2078874108 | ||
| 035 | |a (DE-He213)s11605-022-05295-z-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Dezube, Aaron R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term Outcomes Following Esophagectomy in Older and Younger Adults with Esophageal Cancer |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Society for Surgery of the Alimentary Tract 2022 | ||
| 520 | |a Background Patterns of overall and disease-free survival after esophagectomy for esophageal cancer in older adults have not been carefully studied. Methods Retrospective analysis of all patients with esophageal cancer undergoing esophagectomy from 2005 to 2020 at our institution was performed. Differences in outcomes were stratified by age groups, < 75 and ≥ 75 years old, and two time periods, 2005–2012 and 2013–2020. Results A total of 1135 patients were included: 979 (86.3%) patients were < 75 (86.3%), and 156 (13.7%) were ≥ 75 years old. Younger patients had fewer comorbidities, better nutritional status, and were more likely to receive neoadjuvant and adjuvant therapy (all p < 0.05). However, tumor stage and operative approach were similar, except for increased performance of the McKeown technique in younger patients (p = 0.02). Perioperatively, younger patients experienced fewer overall and grade II complications (both p < 0.05). They had better overall survival (log-rank p-value < 0.001) and median survival, 62.2 vs. 21.5 months (p < 0.05). When stratified by pathologic stage, survival was similar for yp0 and pathologic stage II disease (both log-rank p-value > 0.05). Multivariable Cox models showed older age (≥ 75 years old) had increased hazard for reduced overall survival (HR 2.04 95% CI 1.5–2.8; p < 0.001) but not disease-free survival (HR 1.1 95% CI 0.78–1.6; p = 0.54). Over time, baseline characteristics remained largely similar, while stage became more advanced with a rise in neoadjuvant use and increased performance of minimally invasive esophagectomy (all p < 0.05). While overall complication rates improved (p < 0.05), overall and recurrence-free survival did not. Overall survival was better in younger patients during both time periods (both log-rank p < 0.05). Conclusions Despite similar disease-free survival rates, long-term survival was decreased in older adults as compared to younger patients. This may be related to unmeasured factors including frailty, long-term complications after surgery, and competing causes of death. However, our results suggest that survival is similar in those with complete pathologic responses. | ||
| 650 | 4 | |a Esophagectomy | |
| 650 | 4 | |a Older adults | |
| 650 | 4 | |a Survival | |
| 650 | 4 | |a Recurrence | |
| 650 | 4 | |a Outcomes | |
| 700 | 1 | |a Cooper, Lisa |4 aut | |
| 700 | 1 | |a Mazzola, Emanuele |4 aut | |
| 700 | 1 | |a Dolan, Daniel P. |4 aut | |
| 700 | 1 | |a Lee, Daniel N. |4 aut | |
| 700 | 1 | |a Kucukak, Suden |4 aut | |
| 700 | 1 | |a De Leon, Luis E. |4 aut | |
| 700 | 1 | |a Dumontier, Clark |4 aut | |
| 700 | 1 | |a Ademola, Bayonle |4 aut | |
| 700 | 1 | |a Polhemus, Emily |4 aut | |
| 700 | 1 | |a Bueno, Raphael |4 aut | |
| 700 | 1 | |a White, Abby |4 aut | |
| 700 | 1 | |a Swanson, Scott J. |4 aut | |
| 700 | 1 | |a Jaklitsch, Michael T. |4 aut | |
| 700 | 1 | |a Frain, Laura |4 aut | |
| 700 | 1 | |a Wee, Jon O. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of gastrointestinal surgery |d Springer US, 1997 |g 26(2022), 6 vom: 31. März, Seite 1119-1131 |w (DE-627)320502201 |w (DE-600)2012365-6 |w (DE-576)091140536 |x 1091-255X |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2022 |g number:6 |g day:31 |g month:03 |g pages:1119-1131 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11605-022-05295-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2022 |e 6 |b 31 |c 03 |h 1119-1131 | ||